Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma

Bone ◽  
2010 ◽  
Vol 46 ◽  
pp. S44
Author(s):  
Roger von Moos ◽  
David Henry ◽  
Saroj Vadhan-Raj ◽  
Vania Hungria ◽  
Andrew Spencer ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Multiple Myeloma ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Phase 3 ◽  
Double Blind

scholarly journals Pain Interference Outcomes in a Randomized Phase 3 Clinical Trial of Denosumab vs Zoledronic Acid (ZA) in Patients with Solid Tumors and Bone Metastases

2012 ◽  
Vol 23 ◽  
pp. ix509-ix510
Author(s):  
C. Cleeland ◽  
L. Fallowfield ◽  
R. von Moos ◽  
D. Patrick ◽  
D.H. Henry ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Solid Tumors ◽  
Pain Interference ◽  
Phase 3

Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases

Bone ◽  
2010 ◽  
Vol 46 ◽  
pp. S36-S37 ◽  
Author(s):  
Jean-Jacques Body ◽  
Alison Stopeck ◽  
Yasuhiro Fujiwara ◽  
Allan Lipton ◽  
Guenther Steger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Phase 3 ◽  
Double Blind
Sign in / Sign up

Export Citation Format

Share Document